U.S. markets closed
  • S&P Futures

    3,881.75
    +14.25 (+0.37%)
     
  • Dow Futures

    31,465.00
    +107.00 (+0.34%)
     
  • Nasdaq Futures

    13,133.75
    +78.50 (+0.60%)
     
  • Russell 2000 Futures

    2,246.80
    +17.70 (+0.79%)
     
  • Crude Oil

    59.97
    +0.22 (+0.37%)
     
  • Gold

    1,732.80
    -0.80 (-0.05%)
     
  • Silver

    26.82
    -0.06 (-0.22%)
     
  • EUR/USD

    1.2089
    +0.0001 (+0.01%)
     
  • 10-Yr Bond

    1.4150
    -0.0310 (-2.14%)
     
  • Vix

    24.10
    +0.75 (+3.21%)
     
  • GBP/USD

    1.3964
    +0.0007 (+0.05%)
     
  • USD/JPY

    106.8390
    +0.1290 (+0.12%)
     
  • BTC-USD

    48,815.39
    -645.58 (-1.31%)
     
  • CMC Crypto 200

    977.95
    -8.70 (-0.88%)
     
  • FTSE 100

    6,613.75
    +25.22 (+0.38%)
     
  • Nikkei 225

    29,459.71
    +51.54 (+0.18%)
     

Jim Cramer Weighs In On Berkshire Hathaway, Range Resources, Zynerba And More

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
Brett Hershman
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

On Monday's “Mad Money,” Jim Cramer said he remains bearish on Range Resources Corp. (NYSE: RRC) saying natural gas is the weakest part of the petrol chain.

Cramer says although it's speculative, he is bullish on gene sequencing stock Guardant Health Inc (NASDAQ: GH).

He remains bullish on Berkshire Hathaway Inc. Class B (NYSE: BRK-B) and has been recommending the stock since the show began.

Seattle Genetics, Inc. (NASDAQ: SGEN) is a buy, says Cramer.

Cramer says to steer clear of Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE) and if you want to play cannabinoids, GW Pharmaceuticals PLC-ADR (NASDAQ: GWPH) is what he would buy.

Related Links:

'Halftime Report' Final Trades From July 16: American Airlines, JetBlue And More

'Fast Money' Traders Talk Retail: Costco, Target And More

See more from Benzinga

© 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.